DIgitalis Flashcards
1
Q
A-flutter
A
- macro-re-entrant arrhythmia that circulates in counterclockwise manner in RA
- accompanied by AV block, sawtooth F waves on EKG, best in leads II and V1
- c/w CAD or mitral valve dz, PE, hyperthyroid, cardiac trauma, myocarditis
- Atrial rates 250-350, v rates >150
- regular atrial rhythm, v rhythm regular if fixed AV block, irregular if variable (can be 2:1 to 8:1)
2
Q
treatment aflutter
A
- pharmacologic
- synchronized cardioversion (only after risks of thromboembolic events have been assessed by cardiologist
3
Q
pharmacologic therapy
A
- first line–beta blockers (esmolol), propranolol–slow AV conduction, control ventricular response
- 2nd line CCB-verapamil 5-10 mg, diltiazem
4
Q
synchronized cardioversion
A
- xs rapid ventricular rates, hemodynamic instability
- start 100J, increasing to 360 J
5
Q
other drugs
A
- Class III antiarrhythmics–ibutilide in new onset AF–need to monitor 12 hrs for torsades
- amio 150 over 10 min
- procainamide
6
Q
Afib
A
- rapid atrial focus with no P waves
- irregularly irregular
- loss of atrial kick–impair CO
- atrial thrombi–inc pulm/systemic embolization
- atrial rates 350-500, v rates 60-170
- no p waves
- more likely to assoc with cardiac disease, CAD/mitral valve disease, PE, hyptherthyroid, cardiac trauma, myocarditis
7
Q
cardiac surgery
A
- AF 10% all noncardiac surgery, 30% thoracic, 15-45% cardiac surgeries
- inc morbidity, mortality, hospital stays
- preop beta blockers, periop amio/sotalol/CCB/Mg can help
8
Q
pharma therapy
A
- control ventricular response
- beta blockers (esmolol), CCB (diltiazem)
- ibutilide less effective in restoring sinus rhythm, less often used in afib
9
Q
synchronized cardioversion
A
- biphasic cardioversion for afib with hemodynamic instability
- inc risk of thromboembolism, if Afib>48 hrs, need anticoagulation for 3-4 weeks before cardioverting
10
Q
chronic afib therapy
A
- anticoagulation-coumadin, dabigatran
- V-contorl-b blockers, CCB, digitalis, catheter ablation of AV junction, pacer
- paroxysmal afib–radiofrequency ablation
11
Q
therapy for no sig CAD/LV dysfunc
A
-Class Ic antiarrhythmic–flecainide, propafenone
12
Q
Digitalis formulation
A
-digoxin, digitoxin, oubain–cardiac glycosides
13
Q
indication
A
- CHF and in setting of SVTs like afib, to slow ventricular response
- inhibits Na-K ATPase–inc intracellular calcium and prolonged AV conductance, positive intoropy, inc muscle automaticity